Plasma miR-98-5p as a candidate biomarker of pain severity in oxaliplatin-induced peripheral neuropathy related to NGF and catecholamine dysregulation.

Ju Y, Choi GE, Jang A

Open source

DOI
10.3389/fmolb.2026.1884789
Published
2026
Container
Frontiers in molecular biosciences
Publisher
Not recorded
Open access
yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.3389/fmolb.2026.1884789,
  title = {Plasma miR-98-5p as a candidate biomarker of pain severity in oxaliplatin-induced peripheral neuropathy related to NGF and catecholamine dysregulation.},
  author = {Ju Y and Choi GE and Jang A},
  year = {2026},
  journal = {Frontiers in molecular biosciences},
  doi = {10.3389/fmolb.2026.1884789},
  url = {https://doi.org/10.3389/fmolb.2026.1884789}
}

RIS

TY  - JOUR
TI  - Plasma miR-98-5p as a candidate biomarker of pain severity in oxaliplatin-induced peripheral neuropathy related to NGF and catecholamine dysregulation.
AU  - Ju Y
AU  - Choi GE
AU  - Jang A
PY  - 2026
JO  - Frontiers in molecular biosciences
DO  - 10.3389/fmolb.2026.1884789
UR  - https://doi.org/10.3389/fmolb.2026.1884789
ER  - 

APA

Y, J., GE, C., & A, J. (2026). Plasma miR-98-5p as a candidate biomarker of pain severity in oxaliplatin-induced peripheral neuropathy related to NGF and catecholamine dysregulation.. Frontiers in molecular biosciences. https://doi.org/10.3389/fmolb.2026.1884789

Source records